Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Ecotoxicol Environ Saf ; 182: 109385, 2019 Oct 30.
Article in English | MEDLINE | ID: mdl-31260918

ABSTRACT

The present study was the first approach conducted under environmental concentrations of Gd-DOTA and Gd-DTPA-BMA to assess cellular impacts of these compounds. Gd-DOTA (Gadoteric acid) is one of the most stable contrast agent, currently used as Dotarem® formulation during Magnetic Resonance Imaging exams. The study was mainly performed on a Zebra Fish cell line (ZF4; ATCC CRL-2050). At the concentrations of 0.127 nM and 63.59 nM (respectively 20 ng and 10 µg of Gd/L), we did not observed any toxicity of Dotarem® but a slowdown of the cell growth was clearly measured. The effect is independent of medium renewing during 6 days of cell culturing. The same effect was observed i-with Gd-DOTA on another fish cell line (RT W1 gills; ATCC CRL-2523) and ii-with another contrast agent (Gd-DTPA-BMA - Omniscan®) on ZF4 cells. On the ZF4 cell line, the diminution of the cell growth was of the same order during 20 days of exposure to a culture medium spiked with 63.59 nM of Dotarem® and was reversible within the following 8 days when Dotarem® was removed from the medium. As shown by using modified DOTA structure (Zn-DOTA), the effect may be due to the chelating structure of the contrast agent rather than to the Gd ion. Until now, the main attention concerning the impact of Gd-CA on living cells concerned the hazard due to Gd release. According to our results, quantifying the presence of Gd-CA chelating structures in aquatic environments must be also monitored.


Subject(s)
Contrast Media/toxicity , Gadolinium DTPA/toxicity , Heterocyclic Compounds/toxicity , Meglumine/toxicity , Organometallic Compounds/toxicity , Water Pollutants, Chemical/toxicity , Animals , Biomarkers/analysis , Cell Cycle/drug effects , Cell Line , Cell Survival/drug effects , Chelating Agents , Magnetic Resonance Imaging , Oncorhynchus mykiss , Zebrafish
2.
Nanotechnology ; 28(5): 055705, 2017 Feb 03.
Article in English | MEDLINE | ID: mdl-28029111

ABSTRACT

Chitosan CS-tripolyphosphate TPP/hyaluronic acid HA nanohydrogels loaded with gadolinium chelates (GdDOTA ⊂ CS-TPP/HA NGs) synthesized by ionic gelation were designed for lymph node (LN) MRI. In order to be efficiently drained to LNs, nanogels (NGs) needed to exhibit a diameter ϕ < 100 nm. For that, formulation parameters were tuned, using (i) CS of two different molecular weights (51 and 37 kDa) and (ii) variable CS/TPP ratio (2 < CS/TPP < 8). Characterization of NG size distribution by dynamic light scattering (DLS) and asymetrical flow-field-flow-fractionation (AF4) showed discrepancies since DLS diameters were consistently above 200 nm while AF4 showed individual nano-objects with ϕ < 100 nm. Such a difference could be correlated to the presence of aggregates inherent to ionic gelation. This point was clarified by atomic force microscopy (AFM) in liquid mode which highlighted the main presence of individual nano-objects in nanosuspensions. Thus, combination of DLS, AF4 and AFM provided a more precise characterization of GdDOTA ⊂ CS-TPP/HA nanohydrogels which, in turn, allowed to select formulations leading to NGs of suitable mean sizes showing good MRI efficiency and negligible toxicity.

3.
Nanotechnology ; 25(44): 445103, 2014 Nov 07.
Article in English | MEDLINE | ID: mdl-25325295

ABSTRACT

The incorporation of a lipophilic Gd chelate (GdDO3A-C12) in biocompatible PLGA poly(D, L-lactide-co-glycolide) nanoparticles was explored as an approach to increase the relaxivity of contrast agents for magnetic resonance imaging. By nanoprecipitation, it was possible to obtain PEGylated gadolinium nanoparticles (mean diameter of 155 nm) with high Gd loading (1.1 × 10(4) Gd centers per nanoparticle). The corresponding GdDO3AC12 ⊂ NPs nanoparticles exhibited an enhanced relaxivity (up to sixfold greater than DOTAREM® at 40 MHz) because the nanoparticle framework constrained the lipophilic Gd chelate motion and favorably impacted the Gd chelate rotational correlation time. T1-weighted imaging at 3 T on phantoms showed enhanced contrast for the GdDO3AC12 ⊂ NPs. Importantly, Gd chelate leakage was almost nonexistent, which suggested that these GdDO3AC12 ⊂ NPs could be useful for long-term MRI detection.


Subject(s)
Contrast Media/chemical synthesis , Glioma/diagnosis , Magnetic Resonance Imaging/methods , Nanoparticles/chemistry , Animals , Cell Line, Tumor , Cell Survival/drug effects , Gadolinium/chemistry , Lactic Acid/chemical synthesis , Microscopy, Atomic Force , Nanoparticles/administration & dosage , Particle Size , Polyglycolic Acid/chemical synthesis , Polylactic Acid-Polyglycolic Acid Copolymer , Rats
4.
Neurogastroenterol Motil ; 25(3): e183-93, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23281940

ABSTRACT

BACKGROUND: The systemic rotenone model of Parkinson's disease (PD) accurately replicates many aspects of the pathology of human PD, especially neurodegeneration of the substantia nigra and lesions in the enteric nervous system (ENS). Nevertheless, the precise effects of oral rotenone on the ENS have not been addressed yet. This study was therefore designed to assess the effects of a chronic oral treatment by rotenone on enteric neurochemical phenotype, gastrointestinal (GI) motility, and intestinal epithelial barrier permeability. METHODS: Male C57BL6N mice received once daily oral rotenone administration for 28 days. GI functions were analyzed 4 weeks after rotenone treatment. Gastrointestinal motility was assessed by measuring gastric emptying, total transit time, fecal pellet output, and bead latency. Intestinal barrier permeability was evaluated both in vivo and ex vivo. The number of enteric neurons and the enteric neurochemical phenotype were analyzed by immunohistochemistry. Tyrosine hydroxylase (TH) immunostaining of dopaminergic neurons of the substantia nigra was performed in a subset of animals. KEY RESULTS: Mice treated orally with rotenone had a decrease in fecal pellet output and in jejunal alpha-synuclein expression as compared with control animals. This was associated with a significant decrease in TH-immunoreactive neurons in the substantia nigra. No change in gastric emptying, total transit time, intestinal epithelial barrier permeability, and enteric neurochemical phenotype was observed. CONCLUSIONS & INFERENCES: Chronic oral treatment with rotenone only induced minor changes in the ENS and did not recapitulate the GI abnormalities seen in PD, while it replicates neurodegeneration of the substantia nigra.


Subject(s)
Gastrointestinal Motility/drug effects , Intestinal Mucosa/drug effects , Myenteric Plexus/drug effects , Rotenone/toxicity , Uncoupling Agents/toxicity , Administration, Oral , Animals , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Neurons/drug effects , Rotenone/administration & dosage , Substantia Nigra/drug effects , Uncoupling Agents/administration & dosage
5.
J Biomed Mater Res A ; 101(3): 613-21, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22926966

ABSTRACT

Polypropyleneimines (PPIs) functionalized by glycerol-based entities are prepared and characterized by diffusion-ordered spectroscopy NMR. Showing low cytotoxicity against MRC5 fibroblasts, their encapsulation capacities of gadolinium complexes was evaluated. T(1) measurements were performed to determine the relaxivity of the encapsulated gadopentetate dimeglumine (GdBOPTA) in dendrimers of fourth and fifth generation (GD-PPI-4 and GD-PPI-5). Comparison of the GdBOPTA relaxivity and the relaxivity of GdBOPTA-loaded dendrimers showed a slight increase of the gadolinium chelate relaxivity.


Subject(s)
Contrast Media/chemistry , Dendrimers/chemistry , Gadolinium DTPA/chemistry , Polypropylenes/chemistry , Cell Line , Contrast Media/pharmacology , Dendrimers/pharmacology , Drug Evaluation, Preclinical , Fibroblasts/cytology , Fibroblasts/metabolism , Gadolinium DTPA/pharmacology , Humans , Polypropylenes/pharmacology
6.
Nanotechnology ; 21(16): 165101, 2010 Apr 23.
Article in English | MEDLINE | ID: mdl-20348590

ABSTRACT

A double emulsion-solvent diffusion approach with fully biocompatible materials was used to encapsulate copper complexes within biodegradable nanoparticles, for which the release kinetics profiles have highlighted their potential use for a prolonged circulating administration.


Subject(s)
Absorbable Implants , Biocompatible Materials/chemistry , Copper/chemistry , Drug Implants/chemistry , Lactic Acid/chemistry , Nanoparticles/chemistry , Polyglycolic Acid/chemistry , Diffusion , Kinetics , Materials Testing , Nanoparticles/ultrastructure , Particle Size , Polylactic Acid-Polyglycolic Acid Copolymer , Surface Properties
7.
Int J Pharm ; 379(2): 226-34, 2009 Sep 11.
Article in English | MEDLINE | ID: mdl-19428198

ABSTRACT

PLGA nanoparticles were prepared via a modified W/O/W emulsion solvent diffusion process, in which all formulation components were fully biocompatible and biodegradable. Different independent processing parameters were systematically studied. Nanoparticles were characterized by DLS (particle size, polydispersity, zeta-potential) and TEM/AFM (surface morphology). An optimized formulation was used to encapsulate copper complexes of cyclen and DOTA as potential PET imaging agents. Results showed that the predominant formulation factors appeared to be the lactide-to-glycolide (L:G) ratio of PLGA, the nature of the diffusion phase, and the presence of hydroxyl ions in the first-emulsion aqueous phase. By regulating those 3 parameters, PLGA nanoparticles were prepared with very good preparation yields (>95%), a size less than 200 nm and a polydispersity index less than 0.1. TEM pictures showed nanoparticles with a narrow size distribution, a spherical shape and a smooth surface. The optimized formulation allowed to encapsulate Cu-cyclen and Cu-DOTA complexes with an encapsulation efficiency between 20% and 25%.


Subject(s)
Chemistry, Pharmaceutical/methods , Copper/chemistry , Lactic Acid/chemistry , Nanoparticles/chemistry , Polyglycolic Acid/chemistry , Chemical Phenomena , Particle Size , Polylactic Acid-Polyglycolic Acid Copolymer
8.
Can J Physiol Pharmacol ; 86(1-2): 46-54, 2008.
Article in English | MEDLINE | ID: mdl-18418446

ABSTRACT

The aim of this study was to investigate the effects of adenosine on reverse mode Na+/Ca(2+) exchange. In intact ferret cardiac trabeculae, Na+-free contractures were investigated after treating preparations with ryanodine, a sarcoplasmic reticulum Ca(2+) -channel inhibitor, and thapsigargin, a sarcoplasmic reticulum Ca(2+) -pump inhibitor added to suppress the sarcoplasmic reticulum function. The effects of adenosine (50-100 nmol/L), adenosine deaminase (ADA, 0.1-0.5 U/L), the A1 and A2A receptor agonists CCPA (3-100 nmol/L) and CGS 21680 (25-100 nmol/L), and the A1 and A2A receptor antagonists DPCPX (25 nmol/L) and ZM 241385 (25 nmol/L) were tested on Na+-free contractures. The application of adenosine (50-100 nmol/L) had no significant effect on the characteristics of the Na+-free contractures. However, the results show that treatment with ADA (0.3 U/L), adenosine (> or =50 nmol/L) and CCPA, a specific A1 receptor agonist (3-100 nmol/L), all reduced the Na+-free contracture amplitude. In the presence of ADA, the effects of adenosine and CCPA were also reduced by a specific antagonist of A1 receptors (DPCPX, 25 nmol/L). Furthermore, adenosine, ADA, and CCPA did not affect the properties of the contractile apparatus in Triton-skinned fibres. It is therefore proposed that endogenous adenosine reduced the reverse mode of the Na+/Ca(2+) exchanger by acting on A1 receptors present in the sarcolemmal membrane.


Subject(s)
Adenosine/pharmacology , Myocardial Contraction/drug effects , Sodium-Calcium Exchanger/drug effects , Adenosine/analogs & derivatives , Adenosine Deaminase/pharmacology , Animals , Ferrets , In Vitro Techniques , Muscle Fibers, Skeletal/physiology , Receptor, Adenosine A1/physiology , Receptors, Adenosine A2/physiology
9.
Exp Physiol ; 91(4): 681-91, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16581872

ABSTRACT

In this study, it was shown that adenosine potentiates caffeine-induced Ca2+ release. It was then proposed that the enhancement of the caffeine-induced Ca2+ release might occur by a direct effect on the ryanodine Ca2+ release channel or on other Ca2+ regulation mechanisms. Furthermore, A2A receptors may be functional on the ferret cardiac sarcoplasmic reticulum. Using chemically skinned fibres, experiments were conducted on ferret cardiac muscle to find out whether adenosine and the A1 and A2A adenosine receptor agonists (CCPA and CGS 21680) and antagonists (DPCPX and ZM 241385) affected caffeine-induced Ca2+ release and the Ca2+ sensitivity of contractile proteins. Changes in the caffeine-induced contracture brought about by adenosine and by adenosine-receptor agonists and antagonists were recorded in saponin-skinned fibres (50 microg ml(-1)). Tension-pCa relationships were then obtained by exposing Triton X-100-skinned fibres (1% v/v) sequentially to solutions of decreasing pCa. Adenosine (1-100 nm) and the specific A2A receptor agonist CGS 21680 (1-50 nm) produced a concentration-dependant potentiation of the caffeine-induced Ca2+ release from saponin-skinned fibres. The data plotted versus adenosine and CGS 21680 concentrations displayed sigmoid relationships (Hill relationship), with potentiation of Ca2+ release by 22.2 +/- 1.6 (n = 6) and 10.9 +/- 0.4% (n = 6), respectively. In addition, the potentiation of caffeine-induced Ca2+ release by adenosine (50 nm; 15.3 +/- 1.0%; n = 6) and by CGS 21680 (50 nm; 11.2 +/- 0.4%; n = 6) was reduced by the specific A2A receptor antagonist ZM 241385 (50 nm) to 8.0 +/- 1.4 (n = 4) and 5.4 +/- 1.2% (n = 4), respectively. The A1 receptor agonist CCPA (1-50 nm) and antagonist DPCPX (50 nm) had no significant effects on caffeine responses. In Triton X-100-skinned fibres, the maximal Ca(2+)-activated tension of the contractile proteins (41.3 +/- 4.1 mN mm(-2); n = 8), the Hill coefficient (nH = 2.2 +/- 0.1; n = 8) and the pCa50 (6.15 +/- 0.05; n = 8) were not significantly modified by adenosine (100 nm) or by CGS 21680 (50 nm).


Subject(s)
Adenosine/administration & dosage , Calcium Signaling/physiology , Calcium/metabolism , Myocytes, Cardiac/metabolism , Receptor, Adenosine A2A/metabolism , Sarcoplasmic Reticulum/metabolism , Animals , Calcium Signaling/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Ferrets , Male , Myocytes, Cardiac/drug effects , Sarcoplasmic Reticulum/drug effects
10.
Acta Physiol Scand ; 184(3): 173-86, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15954985

ABSTRACT

AIM: In this study, we investigated Ca2+ loading by the sarcoplasmic reticulum in skeletal muscle from mdx mice, an animal model of human Duchenne's muscular dystrophy, at two stages of development: 4 and 11 weeks. METHOD: Experiments were conducted on fast- (extensor digitorum longus, EDL) and slow- (soleus) twitch muscles expressing different isoforms of Ca2+-ATPase, which is responsible for the uptake of Ca2+ by the sarcoplasmic reticulum. RESULTS: In sarcoplasmic reticulum vesicles, the ATP-dependent activity and sensitivity to cyclopiazonic acid (CPA), an inhibitor of the sarcoplasmic reticulum Ca2+-ATPase, were similar in mdx and normal EDL muscle. Furthermore, in chemically-skinned fibres from both normal and mdx muscles, the presence of CPA induced a decrease in Ca2+ uptake by the sarcoplasmic reticulum. However, the sensitivity to CPA was lower in mdx EDL muscle than in normal muscle. In addition, in EDL muscle from 4-week-old mdx mice, the expression of the slow Ca2+-pump isoform (SERCA2a) was significantly increased, without any accompanying change in slow myosin expression. In contrast, the expression and function of the Ca2+-ATPase in mdx soleus muscles at 4- and 11-weeks of development did not differ from those in age-matched controls. CONCLUSION: These findings show that in dystrophic muscle, where the Ca2+ homeostasis was perturbed, the Ca2+ handling by the sarcoplasmic reticulum was altered in fast-twitch muscle, and this was associated with the expression of the slow isoform of SERCA. In these muscles, reduced Ca2+ uptake could then contribute to an elevated concentration of Ca2+ in the cytosol, and also to Ca2+ depletion of the sarcoplasmic reticulum.


Subject(s)
Calcium-Transporting ATPases/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Indoles/pharmacology , Muscle, Skeletal/drug effects , Sarcoplasmic Reticulum/metabolism , Animals , Calcium/pharmacokinetics , Calcium-Transporting ATPases/analysis , Immunohistochemistry/methods , Male , Mice , Mice, Inbred mdx , Muscle Contraction/physiology , Muscle Proteins/metabolism , Muscular Dystrophy, Duchenne/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods , Sarcoplasmic Reticulum/enzymology , Sarcoplasmic Reticulum Calcium-Transporting ATPases
11.
Naunyn Schmiedebergs Arch Pharmacol ; 364(3): 259-68, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11521169

ABSTRACT

The present study performed on chemically skinned skeletal fibres was designed to compare the effects of adenosine on the Ca2+ sensitivity of contractile proteins and on caffeine-induced Ca2+ release in rat slow- (soleus) and fast-twitch (edl) muscles. The tension-pCa relationships were obtained by exposing triton X-100 (1% v/v) skinned fibres sequentially to solutions of decreasing pCa in the presence or in absence of adenosine. Then, changes in caffeine contracture due to adenosine were recorded on saponin (50 microg/ml) skinned fibres. The results show that the sensitivity to Ca2+ of contractile proteins in the presence of different concentrations of caffeine was not significantly modified by adenosine. However, it was proposed that adenosine (0.1-2 mM) reduced the Ca2+ released by caffeine (0.1-10 mM) from the sarcoplasmic reticulum in slow- and fast-twitch fibres and that the soleus was more sensitive to adenosine than edl muscle. The effects of specific A2a and A1 agonists and antagonists were also tested on caffeine contractures. It was found that the A1 antagonist reduced adenosine effect on caffeine response. Then it is proposed that adenosine modulates the sarcoplasmic reticulum Ca2+ release by a direct effect on the RyR1 receptors and/or by an indirect effect mediated by A1 receptors located at the sarcoplasmic level.


Subject(s)
Adenosine/pharmacology , Caffeine/antagonists & inhibitors , Central Nervous System Stimulants/antagonists & inhibitors , Muscle Contraction/drug effects , Muscle, Skeletal/drug effects , Vasodilator Agents/pharmacology , Animals , Calcium/metabolism , Dose-Response Relationship, Drug , Male , Muscle, Skeletal/metabolism , Rats , Rats, Wistar , Sarcoplasmic Reticulum/drug effects
12.
Acta Physiol Scand ; 172(1): 27-37, 2001 May.
Article in English | MEDLINE | ID: mdl-11437737

ABSTRACT

This study investigated the effect of caffeine on the sarcolemmal mechanisms involved in intracellular calcium control. Ferret cardiac preparations were treated with ryanodine and thapsigargin in order to eliminate the sarcoplasmic reticulum (SR) function. This treatment abolished caffeine contracture irreversibly in normal solution. The perfusion with K-free medium that blocked the Na+--K+ pump resulted in a recovery of slow relaxing caffeine contractures similar to Na-free contractures. The amplitude of caffeine contractures was dependent on the bathing [caffeine]o and [Ca2+]o. Divalent cations Ni2+ and Cd2+, which have an inhibitory effect on the Na+/Ca2+ exchanger, produced dose-dependent inhibition of caffeine responses with apparent Ki of 780 +/- 19 and 132 +/- 5 microM, respectively. Caffeine also caused dose-dependent inhibition of Na-free contractures (Ki=4.62 +/- 1.5 mM), and the reduction or removal of [Na+]o exerted an inhibitory effect on caffeine contractures (Ki=73.5 +/- 17.12 mM). These experiments indicate that the increase in resting tension following exposure to caffeine was mediated by Na+/Ca2+ exchanger, which represents an additional element of complexity in caffeine action on cardiac muscle.


Subject(s)
Caffeine/pharmacology , Heart Ventricles/drug effects , Myocardial Contraction/drug effects , Myocardium/metabolism , Sodium-Calcium Exchanger/metabolism , Animals , Calcium/pharmacology , Dose-Response Relationship, Drug , Ferrets , Heart Ventricles/metabolism , In Vitro Techniques , Perfusion , Potassium/pharmacology , Ryanodine/pharmacology , Sarcoplasmic Reticulum/drug effects , Thapsigargin/pharmacology
13.
Ann Dermatol Venereol ; 128(11): 1225-8, 2001 Nov.
Article in French | MEDLINE | ID: mdl-11908167

ABSTRACT

BACKGROUND: We report three new cases of patients presenting scurvy. In the year 2000 this rare disease still occurs in France. CASE REPORTS: The three patients, 2 men and a woman respectively 51, 50, and 73 years-old were alcoholics, and lived alone in difficult social conditions. Dietary survey indicated in the 3 cases inadequate vitamin C intake, and a regimen including solely bread, rice, pasta, and packet soup devoid of fresh vegetables and fruit. The cutaneous findings attributed to scurvy were: in the first patient, a woody inflammatory and painful oedema of the left leg associated with perifollicular petechial haemorrhages over the lower limbs, and hyperpigmentation of the facial skin with slate-gray spotty pigmentation of the tongue (pseudo-addisonian hyperpigmentation); in the second patient, an accentuation of a pre-existing acne becoming more inflammatory and extensive; and in the third patient, a diffuse petechial eruption on the abdomen and lower extremities. The diagnosis of scurvy was confirmed by low plasma ascorbic acid levels (< 6 mumol/l). All patients were treated with 1 to 2 g of oral ascorbic acid daily for 2 weeks resulting in rapid and dramatic response. DISCUSSION: Scurvy is a rare disease in industrialized nations. Its incidence is unknown because of absence of total census. Dietary vitamin C deficiency represents the main risk factor exposing for scurvy among adults, often alcoholics and living in social isolation. Cutaneous features supporting the diagnosis of scurvy are described in our observations. The recognition of these cutaneous abnormalities is important because their association can be misleading, and erroneously interpreted as a sign of systemic vasculitis, or connective tissue disease. The diagnosis of scurvy is confirmed by the measurement of plasma ascorbic acid levels. Treatment is simple and based on the administration of vitamin C, which results in dramatic improvement.


Subject(s)
Scurvy/diagnosis , Aged , Alcoholism/complications , Ascorbic Acid/administration & dosage , Cross-Sectional Studies , Diagnosis, Differential , Feeding Behavior , Female , Humans , Incidence , Life Style , Male , Middle Aged , Scurvy/drug therapy , Scurvy/epidemiology
14.
Jpn J Physiol ; 51(6): 661-9, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11846956

ABSTRACT

This study investigated whether the sarcoplasmic reticulum Ca(2+) content of rat skeletal muscle fibers affected contractile responses obtained by an application of 4-chloro-m-cresol (4-CmC) and caffeine. Contractures were elicited on saponin-skinned fibers under different Ca(2+) loading conditions. The amplitude of 4-CmC and caffeine contractures of fast-twitch muscle fibers (edl, extensor digitorum longus) differed between the different loading conditions, and this is associated with a greater change in sensitivity to 4-CmC. When the sarcoplasmic reticulum was loaded with a low Ca(2+) concentration for a short period, the 4-CmC concentration providing half-maximal response was tenfold higher than with a larger sarcoplasmic reticulum Ca(2+) loading for a longer period, whereas for caffeine this concentration was only twofold higher in the same conditions. These findings indicate that 4-CmC contractile responses of edl muscle fibers are more dependent on luminal Ca(2+) activity than those of caffeine are. Thus 4-CmC would appear to be of greater interest than caffeine for the study of muscle contractile responses where variations in intracellular Ca(2+) activity exist.


Subject(s)
Calcium/metabolism , Muscle Contraction/physiology , Muscle Fibers, Skeletal/metabolism , Sarcoplasmic Reticulum/metabolism , Animals , Caffeine/pharmacology , Cresols/pharmacology , Dose-Response Relationship, Drug , Fungicides, Industrial/pharmacology , Male , Muscle Contraction/drug effects , Muscle Fibers, Skeletal/cytology , Muscle, Skeletal/cytology , Muscle, Skeletal/physiology , Phosphodiesterase Inhibitors/pharmacology , Rats , Rats, Wistar , Ryanodine Receptor Calcium Release Channel/metabolism , Weight-Bearing
15.
J Pharmacol Exp Ther ; 294(3): 884-93, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10945837

ABSTRACT

Contractile responses to 4-chloro-m-cresol (4-CmC) were tested in saponin- and Triton X-100-skinned fibers from soleus and edl (extensor digitorum longus) muscles of adult rats and compared with those to caffeine. The testing of different concentrations of 4-CmC on saponin-skinned fibers showed that 4-CmC induced a dose-dependent caffeine-like transient contractile response in edl and soleus due to an activation of the ryanodine receptor. Both types of skeletal muscles showed a 10 to 20 times lower 4-CmC threshold concentration and EC(50) value (concentration providing 50% of the maximal 4-CmC contracture) than for caffeine. The results indicate that edl is more sensitive than soleus to 4-CmC and that this difference in sensitivity is more marked than with caffeine. Furthermore, an increase in cytosolic Ca(2+) activity induced a more marked shift of dose-response curves toward lower concentrations for 4-CmC than caffeine. Experiments conducted on Triton X-100-skinned fibers showed that in both muscles, 4-CmC decreased in a dose-dependent manner the Ca(2+)-activated force of contractile apparatus, particularly in edl. Furthermore, the tension pCa curves indicated that 4-CmC induced a dose-dependent sensitizing (soleus) or desensitizing (edl) effect on the Ca(2+) sensitivity of myofibrils. These results indicate that edl and soleus contractile responses can be discriminated with 4-CmC instead of caffeine and that care must be taken in interpreting results because muscular pathology could be due in part to an increase in intracellular Ca(2+).


Subject(s)
Caffeine/pharmacology , Cresols/pharmacology , Muscle Contraction/drug effects , Muscle Fibers, Fast-Twitch/drug effects , Muscle Fibers, Slow-Twitch/drug effects , Muscle, Skeletal/drug effects , Animals , Calcium/metabolism , Contractile Proteins/physiology , In Vitro Techniques , Male , Muscle Fibers, Fast-Twitch/physiology , Muscle Fibers, Slow-Twitch/physiology , Muscle, Skeletal/physiology , Muscle, Skeletal/ultrastructure , Octoxynol , Rats , Ryanodine Receptor Calcium Release Channel/drug effects , Sarcoplasmic Reticulum/metabolism , Surface-Active Agents
16.
J Appl Physiol (1985) ; 88(5): 1623-30, 2000 May.
Article in English | MEDLINE | ID: mdl-10797122

ABSTRACT

The purpose of the present work was to see whether changes in rat soleus characteristics due to 3 wk of hindlimb suspension could be modified by ciliary neurotrophic factor (CNTF) treatment. Throughout the tail suspension period, the cytokine was delivered by means of an osmotic pump (flow rate 16 microg. kg(-1). h(-1)) implanted under the hindlimb skin. In contrast to extensor digitorum longus, CNTF treatment was able to reduce unweighting-induced atrophy in the soleus. Twitch and 146 mM potassium (K) tensions, measured in small bundles of unloaded soleus, decreased by 48 and 40%, respectively. Moreover, the time to peak tension and the time constant of relaxation of the twitch were 48 and 54% faster, respectively, in unloaded soleus than in normal muscle. On the contrary, twitch and 146 mM K contracture generated in CNTF-treated unloaded and normal soleus were not different. CNTF receptor-alpha mRNA expression increased in extensor digitorum longus and soleus unloaded nontreated muscles but was similar in CNTF-treated unloaded muscles. The present results demonstrate that exogenously provided CNTF could prevent functional changes occurring in soleus innervated muscle subject to unweighting.


Subject(s)
Ciliary Neurotrophic Factor/pharmacology , Muscle, Skeletal/drug effects , Muscle, Skeletal/physiology , Weightlessness , Animals , Atrophy , Body Weight/physiology , Hindlimb Suspension , Isometric Contraction/drug effects , Isometric Contraction/physiology , Male , Muscle, Skeletal/pathology , Potassium/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptor, Ciliary Neurotrophic Factor/genetics
18.
Pflugers Arch ; 441(1): 108-17, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11205048

ABSTRACT

Previous reports have shown that cooling striated muscles induces contractile responses that are related to Ca2+ release from the sarcoplasmic reticulum. However, the effect of cooling has generally been studied in the presence of pharmacological agents that potentiate rapid cooling-induced contractures. The present study shows that in saponin-skinned rat skeletal muscle preparations, a drop in temperature from 22 degrees C to 2 degrees C per se induces a contracture which relaxes on return to 22 degrees C. In fast-twitch fibres, rapid cooling-induced contractures are fully blocked by ryanodine, an inhibitor of ryanodine receptors. By contrast, in slow-twitch fibres, ryanodine partially inhibits the rapid cooling-induced contractile response, leaving a residual tension that dissipates after application of inositol 1,4,5-trisphosphate (InsP3). At low concentrations, heparin, an inhibitor of InsP3 receptors, decreases rapid cooling-induced contractures in both types of muscle. The present results suggest that in skeletal muscle, rapid cooling-induced contractures are due to both ryanodine-sensitive and InsP3-sensitive Ca2+ release from the sarcoplasmic reticulum.


Subject(s)
Calcium Channels/physiology , Calcium/metabolism , Cold Temperature , Contracture/etiology , Receptors, Cytoplasmic and Nuclear/physiology , Ryanodine Receptor Calcium Release Channel/physiology , Sarcoplasmic Reticulum/metabolism , Animals , Calcium/pharmacology , Heparin/pharmacology , Inositol 1,4,5-Trisphosphate/pharmacology , Inositol 1,4,5-Trisphosphate Receptors , Male , Muscle Fibers, Fast-Twitch , Muscle Fibers, Skeletal , Muscle Fibers, Slow-Twitch , Muscle, Skeletal , Rats , Rats, Wistar , Receptors, Cytoplasmic and Nuclear/antagonists & inhibitors , Ryanodine/antagonists & inhibitors , Ryanodine/pharmacology , Saponins/pharmacology
19.
Pflugers Arch ; 438(6): 804-16, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10591069

ABSTRACT

Inositol 1,4,5-trisphosphate (InsP3), an intracellular messenger, induces Ca2+ release in various types of cells, particularly smooth muscle cells. Its role in skeletal muscle, however, is controversial. The present study shows that the application of InsP3 to rat slow- and fast-twitch saponin-skinned fibres induced contractile responses that were not related to an effect of InsP3 on the properties of the contractile proteins. The amplitude of the contractures was dependent upon the Ca(2+)-loading period, and was larger in slow- than in fast-twitch muscle. In both types of skeletal muscle, these responses, unlike caffeine contractures, were not inhibited by ryanodine (100 microM), but were abolished by heparin (20 micrograms.ml-1). In soleus muscle, the concentration of heparin required to inhibit the response by 50% (IC50) was 5.7 micrograms.ml-1, a similar value to that obtained previously in smooth muscle. Furthermore, the results show that in slow-twitch muscle, the InsP3 contractures have a "bell-shaped" dependency on the intracellular Ca2+ concentration. These results show that InsP3 receptors should be present in skeletal muscle. Thus, it is possible that InsP3 participates in the regulation of sarcoplasmic reticulum Ca2+ release in skeletal muscle, particularly in slow-twitch fibres.


Subject(s)
Calcium/metabolism , Inositol 1,4,5-Trisphosphate/pharmacology , Muscle Fibers, Fast-Twitch/metabolism , Muscle Fibers, Slow-Twitch/metabolism , Animals , Calcium/physiology , Heparin/pharmacology , Histological Techniques , Male , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Muscle, Skeletal/physiology , Rats , Rats, Wistar , Ryanodine/pharmacology , Sarcoplasmic Reticulum/drug effects , Sarcoplasmic Reticulum/metabolism
20.
J Pharmacol Exp Ther ; 290(2): 578-86, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10411565

ABSTRACT

The purpose of this study was to determine whether 4-chloro-m-cresol (4-CmC) could generate caffeine-like responses in ferret cardiac muscle. The concentration dependence of 4-CmC-mediated release of Ca(2+) from the sarcoplasmic reticulum was studied in intact cardiac trabeculae and saponin-skinned fibers in which the sarcoplasmic reticulum was loaded with Ca(2+). In intact and saponin-skinned preparations isolated from right ventricle, the effect of 4-CmC on sarcoplasmic reticulum Ca(2+) content was estimated by analysis of caffeine contracture after application of chlorocresol. In addition, the effects of 4-CmC on maximal Ca(2+)-activated tension and the Ca(2+) sensitivity of myofibrils were analyzed by using Triton-skinned cardiac fibers. The results show that 4-CmC generates a contractile response in saponin-skinned but not intact fibers. The sarcoplasmic reticulum is implicated in the 4-CmC response; more precisely, in Ca(2+) release via the ryanodine receptor. Moreover, 4-CmC, like caffeine, has effects on maximal Ca(2+)-activated tension and the Ca(2+) sensitivity of myofibrils.


Subject(s)
Calcium/metabolism , Cresols/pharmacology , Muscle Fibers, Skeletal/metabolism , Myocardium/metabolism , Sarcoplasmic Reticulum/metabolism , Animals , Caffeine/pharmacology , Contractile Proteins/metabolism , Ferrets , Heart Ventricles/drug effects , Heart Ventricles/metabolism , Heart Ventricles/ultrastructure , In Vitro Techniques , Kinetics , Male , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/ultrastructure , Myocardial Contraction/drug effects , Myocardium/cytology , Myocardium/ultrastructure , Octoxynol/pharmacology , Ryanodine Receptor Calcium Release Channel/drug effects , Ryanodine Receptor Calcium Release Channel/metabolism , Saponins/pharmacology , Sarcoplasmic Reticulum/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...